Zsírmáj (MASLD/MASH): vizsgálatok itt: Új-Zéland

In Új-Zéland 6 Also abroad 367

6 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

3. fázisTaking people
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Where
Christchurch, Grafton, Hamilton, Papatoetoe
Életkor
18 év and over
People
1800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00
3. fázisTaking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Christchurch, Grafton, Hamilton, Papatoetoe
Életkor
18 év and over
People
1590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
3. fázisTaking people
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Where
Auckland, Whangarei
Életkor
18 év and over
People
4500 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00
3. fázisTaking people
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Where
Wellington
Életkor
18 év to 75 év
People
1250 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07221188 · EU 2025-523674-16-00
1/2. fázisTaking people
A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)
Where
Auckland
Életkor
18 év to 75 év
People
56 worldwide
Run by
Kriya Therapeutics, Inc.
See details and how to joinNCT07732400
3. fázisTaking people
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Where
Wellington
Életkor
18 év to 75 év
People
1200 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07221227